CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)

Clinical trial NCT01010061 · COMPLETED

Trial details

NCT number: NCT01010061
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic

Start date: 2009-12-21
Primary completion: 2012-07-01
Enrollment: 787

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.